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Exercise training plays a major role in the improving physiology of diabetes. Herein we aimed to investigate the 
influence of exercise upon the calcium-dependent calpain-isoform expressions of lean or obese Zucker rats, a 
model of obesity and type II diabetes (NIDDM). Five-month-old rats were divided: (1) obese sedentary (OS, n=7); 
(2) obese exercise (OE, n=7); (3) lean sedentary (LS, n=7); (4) lean exercise (LE, n=7). After 2-month exercise 
(treadmill running), the body weight (BW) and expression of calpain 10, μ-calpain, and m-calpain in skeletal 
muscles were determined by RT-PCR, using β-actin as internal standard. We found exercise is useful for BW 
lossing, especially in the obese rats. The BW difference between OS and OE rats (69 g vs. 18.2 g) was more sig-
nificantly than that between LS and LE rats (41.8 g vs. 28.7g). The calpain 10 expression of LS rats (0.965) was 
lower than that of LE rats (1.006), whereas those of OS and OE were comparable. The μ- or m-calpain expressions 
of sedentary groups (OS, LS) was significantly higher than those of exercise groups (OE, LE). The μ-calpain ex-
pression (1.13/0.92) and m-calpain expression (1.01/0.99) of OS/LS rats was significantly higher than those of 
OE/LE rats [1.07/0.9 (μ-calpain); 0.97/0.95 (m-calpain)]. We concluded that the μ- or m-calpains in skeletal 
muscle are regulated by exercise in both lean and obese Zucker rats. Exercise and BW controlling might improve 
the physiopathology of obesity and diabetes. Both μ- or m-calpains might become useful markers for prognoses 
of diabetes.  
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Introduction 
Diabetes is a multifactorial and heterogeneous 
disorder with both genetic and environmental factors 
contributing to its development. Type 2 or 
non-insulin-dependent diabetes mellitus (NIDDM) is 
the most common form of diabetes, affecting ap-
proximately 4% of world's adult population. NIDDM 
is resulted from the contribution of many genes inter-
acting with different environmental factors, which 
produce wide variation in the clinical courses. The 
dramatic worldwide prevalence of NIDDM over the 
past decades might be resulted from the relatively re-
cent changes in diet, life style and physical activities.  
Skeletal muscle is the standard organ of insu-
lin-mediated glucose uptake. Exercise increases the 
rate of glucose uptake into the contracting skeletal 
muscle [1]. This effect of exercise is similar to the action 
of insulin on glucose uptake. Exercise increases skele-
tal muscle glucose uptake, which involves the trans-
location of glucose transporters to the plasma mem-
brane and transverse tubules. Exercise decreased he 
basal and glucose-induced plasma insulin levels and 
improved sensitivity to insulin in obese humans [2,3].   
Zucker diabetic fatty rat (ZDF, fa/fa) presents a 
range of metabolic aberrations such as hyperglycemia, 
hyperinsulinemia, hyperlipidemia, and adipocyte hy-
pertrophy, which are similar to those of NIDDM indi-
viduals as well as useful animal model for NIDDM [4, 
5]. Exercise training has been present to improve the 
severe insulin resistance found in ZDF rats and to re-
duce plasma insulin [1]. The mechanism  through 
which exercise training improves the skeletal muscle Int. J. Biol. Sci. 2008, 4 
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insulin resistance of the ZDF rats has yet to be fully 
elucidated [6].  
Calcium-dependent proteinase (calpain) system 
has been found in every vertebrate cell. The contrac-
tions of skeletal muscle are associated with cal-
cium-dependent protease and calpain system [7, 8]. 
Calpain is a cytoplasmic cysteine protease activated by 
calcium ions [9]. Calpains are calcium-modulated pro-
teases which respond to calcium signals by removing 
limited portions of protein substrates, thereby irre-
versibly modifying their functions. Calpain-isoforms 
take part of a variety of calcium-regulated  cellular 
processes such as signal transduction, cell prolifera-
tion,  cycle progression, differentiation, apoptosis, 
membrane fusion, and platelet activation [14-17]. Fur-
thermore, calpain has been reported to be associated 
with the risk of NIDDM [10,18,19].  
Since exercise increases the rate of glucose uptake 
of skeletal muscle as well as improving the patho-
physiology of NIDDM individuals, it is logical to sus-
pect its influences upon the presentations of cal-
pain-isoforms. Reviewing the related literatures, the 
mechanism through which exercise training improves 
the calpain presentation remains obscure. Herein we 
firstly intended to evaluate the effects of exercise upon 
the body weight and calpain-isoform (calpain 10, 
μ-calpain, m-calpain) expressions of obese and lean 
zucker rats.  
Materials and Methods 
Animals  
The studies were performed on lean (Fa/Fa or 
Fa/fa) and obese (fa/fa) male Zucker rats with genetic 
mutation during 5 months old [5]. Zucker rats were 
born by breeders purchased from Charles River Lab in 
France. Each rat was housed in a separate cage. All 
groups of rats were studied at the same age. Their BWs 
b e f o r e  e x e r c i s e  w e r e  c o m p a r a b l e .  M e a n  B W  i n  e a c h  
group (OS/OE/LS/LE) were 56.3, 55.9, 38.7, 37.9g, 
respectively. The ambient temperature was main-
tained between 22-24ºC and the animals were kept on 
an artificial 12-h light-dark cycle. The light period be-
gan at  7:00 A.M. Rats were provided with standard 
laboratory chow and water [5]. All protocols were ap-
proved by the Institutional Animal Care and Use Com-
mittee (China Medical University, Taichung, Taiwan).  
Exercise Training 
A total of 14 lean and 14 obese rats were ran-
domly divided into four age-matched groups: (1) lean 
sedentary (LS, n=7); (2) lean exercise (LE, n=7); (3) 
obese sedentary (OS, n=7), and (4) obese exercise (OE, 
n=7). Initially, 28 rats were screened whether they 
could run on a motor-driven treadmill at 20 m/min, 
0% incline, for 60 min. Rats in the exercise groups were 
trained by running for 8 weeks on a motorized tread-
mill in the morning. For exercise experiments, obese 
Zucker rats received one session of exercise, which 
consisted of running on a treadmill at 20 m/min, 0% 
incline, for 60 min. The exercise intensity for both OE 
and LE rats was approximately 70% of the peak pul-
monary oxygen consumption (59.6+1.3mL/kg per 
min) [5]. Training protocols were began when the rats 
were 5 months old and finished when rats were 7 
months old. Lean and obese rats in the sedentary 
groups (LS, OS) were removes from their cages once a 
day for 7 day/week and placed on the stationary 
treadmill for 60 min to account for handling stress.  
RNA extraction and Reverse transcription reaction 
All rats were killed with overdosage-anesthesia 
(isofluorane) at 48 h after the end of their last training 
session to minimize acute exercise effects from the last 
training bout. Rats in the sedentary groups were killed 
at the same time as their trained counterparts. The 
RNA extraction and RT-PCR procedures were per-
formed as previous described [20]. After all rats had 
been killed, all tissues were removed immediately and 
washed with cold phosphate buffer. These tissues 
were cut into potions and stored separately at -70
°C. In 
this survey, only skeletal muscles from bilateral legs 
were used for analyses. Total RNAs from the skeletal 
muscle were extracted by Trizon (Invitrogen). One 
microgram of each total RNA was reverse transcribed 
into cDNA using the RNA PCR kit (Invitrogen) using 
oligo (dT) primer. The reaction was carried out at 50
°C 
for 60 min. The reverse transcriptase was inactivated 
with incubation at 98
°C for 5 min, and kept at 4
°C.  
PCR conditions 
The reverse transcription reaction products were 
measured by PCR analysis, using mRNA encoding rat 
β-actin as an internal standard. All PCR reactions were 
performed as follows: 1 µl of cDNA was used for am-
plification with 1 U Taq DNA polymerase (Qiagen, 
Hilden, Germany), 5µl PCR buffer, 5µl 10 mM dNTPs 
(each), and 1 pmol of each specific upstream and 
downstream primer. The individual primer sequences 




3'-TTGTGGGGCTCGAAGG TGGAGGG; Calpain 10: 
5'- AACCCAGCGAGGTGTGTGTGGCTGTT and 
3'-GCAGTGTTGCTGTAGGGTGATACGGATG. PCR 
amplification was performed using the following con-
ditions: 94
°C for 5 min, then 30 cycles of 94
°C for 1 min, 
55
°C for 1 min, and 72
°C for 1 min, with a final elonga-
tion of 72
°C for 7 min. The PCR products were ana-Int. J. Biol. Sci. 2008, 4 
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lyzed by electrophoresis in 2% agarose gel containing 
0.5 μg/ml ethidium bromide.  
Preparation of tissue and cell extracts for Western 
blotting 
Obese Zucker rats skeletal muscle were homoge-
nized in ice-cold Buffer B (20 mM Tris-HCl (pH 7.5), 
0.25 M sucrose, 50 mM β-mercaptoethanol, 1mM 
PMSF, 200 μg/ml of leupeptin, 5 mM EDTA, 2 mM 
EGTA, 10 mM benzamidine) using a homogenizer. 
Tissues were centrifuged at 100,000×g for 30 min at 
4ºC. Supernatants were used as the cytosolic fraction. 
To obtain membrane fractions, the pellets were 
washed and extracted with Buffer B containing 1% 
Triton X-100. After 30 min incubation at 4ºC, the sam-
ples were centrifuged at 100,000×g for 30 min yielding 
the solubilized membrane fraction.  
Protein concentrations of individual samples 
were determined by the protein-dye binding reaction 
on an acetate membrane and a light microscope with 
an automatic exposure instrument [21]. In briefly, the 
protein was stained with Coomassie Brilliant Blue 
G-250 (Nacalai Tesque, Inc, Kyoto, Japap) and ab-
sorbed by discoidal cellulose acetate membranes 
(Jooko Sangyo, Co., Ltd, Tokyo, Japan), which was 
further examined by a light microscope. A liner rela-
tion was detected between the intensity of dye binding 
to protein and exposure time. 
Western blot analysis of μ-calpain and m-calpain 
Protein samples were subjected to 10% 
SDS-PAGE according to the method of Laemmli [22]. 
In briefly, nuclear extracts were incubated in buffer at 
37oC for 10 min and fractionated by electrophoresis. 
The separated protein were electrophoretically trans-
ferred to a 0.22 µm nitrocellulose membranes (Hy-
bond-C Super or Hybond-ECL) at 4ºC overnight using 
a Bio-Rad Transfer Blot apparatus (30 mAmp). Non-
specific sites were blocked with 5% skim milk in TTBS 
(50mM Tris-HCl, pH 7.5, 0.15 M NaCl, 0.05% 
Tween-20) for 1 h at room temperature. The mem-
branes were incubated for 2 hr at room temperature 
and were sequentially diluted with 1:2500 of 
anti-rabbit  μ- or m-calpain. The membranes were 
washed and incubated for 1 hr with 1:2000 dilution of 
secondary (AP-conjugated goat anti-rabbit IgG). After 
three time washings, antibody-reactive bands were 
visualized by the ECL detection system (Amersham). 
The blots were scanned using a Gene Gnome syngene 
Bio imaging system. 
Statistical analysis 
All data were presented as mean ± standard de-
viation (SD). The SAS system (Version 8.1, SAS Insti-
tute Inc., Cary, North Carolina, USA) with unpaired 
student’s t-test was utilized for statistical analyses. A 
p-value <0.05 was considered statistically significant.  
Results 
Body weight  
In both lean and obese rats, the final body weight 
of sedentary group was significantly higher than that 
of exercise group. The BW difference between OS and 
OE rats was more significantly than that between LS 
and LE rats. After exercise training for 8 weeks, in 
obese group, the final body weight of OS rats was 
higher than those of OE rats (69±19.2 g vs. 18.17±11.09 
g, p<0.001, Figure 1A). In the lean group (non-diabetic 
rats), the body weight of LS was also higher than those 
of LE (41.75 ± 2.87 g vs. 28.67 ± 6.41 g, p<0.05, Figure 
1B). The differences of body weight between exercise 
and sedentary groups were due to the influences of 
massive exercise.   
Calpains mRNA expression in skeletal muscle 
In obese group, there were no significant differ-
ences in calpains 10 mRNA expression of skeletal 
muscle between sedentary (OS ) and exercised rats 
(OE) (1.105 ± 0.0311 vs. 1.072 ± 0.0084, p= 0.053; Figure 
2A). In contrast, in the lean group, the calpain 10 
mRNA expression of sedentary rats (LS) was signifi-
cantly lower than in exercise rats (LE) (0.965 ± 0.031 vs. 
1.006  ± 0.024; p  <  0.05; Figure 2B). In both lean and 
obese rats, the μ- or m-calpain expressions of sedentary 
group was higher than those of exercise group. In 
obese groups, the μ-calpain mRNA expression of 
skeletal muscle in sedentary rats (OS) was higher than 
that in exercised rats (OE) (1.13 ± 0.038 vs. 1.068 ± 0.023; 
p< 0.05; Figure 3A). In the lean groups, the μ-calpain 
expression of LS rats was higher than that of LE rats 
(0.92 ± 0.014 vs. 0.898 ± 0.013, p < 0.05; Figure 3B). The 
m-calpain expression of OS/LS rats was also higher 
than that of OE/LE rats (1.01 ± 0.0141/0.995 ± 0.0173 
vs. 0.97 ± 0.021/0.9467 ± 0.0137, p<0.05, 0.001, respec-
tively, Figure 4A,B). In obese groups, the m-calpain 
mRNA expression of skeletal muscle in sedentary rats 
(OS) was higher than that in exercised rats (OE) (1.01 ± 
0.014 vs. 0.97 ± 0.021; P < 0.05; Figure 4A). In the lean 
groups, the m-calpain expression of LS rats was also 
higher than that of LE rats (0.995 ± 0.017 vs. 0.947 ± 
0.014, P < 0.001; Figure 4B).  
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Figure 1. Body weights of (A) obese and (B) lean Zucker rats after sedentary or exercise treatment.  
    
Figure 2. Electrophoreses and expression ratios of calpain 10 and β-actin mRNA in skeletal muscle of (A) obese and (B) lean Zucker 
rats after sedentary or exercise treatment.  Int. J. Biol. Sci. 2008, 4 
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Figure 3. Electrophoreses and expression ratios of μ-calpain and β-actin mRNA in skeletal muscle of (A) obese and (B) lean Zucker 
rats after sedentary or exercise treatment.  
      
Figure 4. Electrophoreses and expression ratios of m-calpain and β-actin mRNA in skeletal muscle of (A) obese and (B) lean Zucker 




Western blot analysis of calpain 
Effects of exercise on cytosolic and mem-
brane-bound m- and μ-calpain in skeletal muscle of 
obese Zucker rats were determined by Western blot 
analysis. The protein levels of membrane-bound m- 
and  μ-calpain between obese-sedentary (OS) and 
obese-exercise (OE) rats were presented on Figure 5A 








Figure 5. Effects of exercise on cytosolic and membrane-bound 
(A) μ- and (B) m-calpain in skeletal muscle of obese Zucker 
rats. The protein levels were determined by Western blot 
analysis. The α-tubulin is internal control.  
 
Discussion 
The calpain system, a family of cal-
cium-dependent cysteine protease, has been found for 
decades [23]. These calpain-isoforms might act inde-
pendently through different proteosome pathway and 
cleave a number  of cellular substrates, including 
kinases, phosphatases, transcription  factors, and cy-
toskeletal proteins [24]. Calpain activity has been as-
sociated with cleavages that alter regulation of various 
enzyme activities, with remodeling or disassembly of 
the cell cytoskeleton, and with cleavages of hormone 
receptors [14]. Calpains involved in variety of physio-
logical and pathological disorders [25]. Alterations in 
calpain-isoform activity might be related with a num-
ber of disorders, including stroke [26,27],  traumatic 
brain injury [26,27], Alzheimer's disease [26,27], cata-
racts [27], limb-girdle muscular dystrophy [26,27] and 
gastric cancer [26].  
At least 14 members of calpain-isoforms have 
been identified [26], including μ-calpain, m-calpain, 
and calpain-10 [28]. Both μ- and m-calpain are het-
erodimers containing a 30 KD small subunit and an 80 
KD large subunit, which require micro-molar and 
milli-molar calcium concentrations for activation [9,11, 
29]. The μ-calpain is accompanied by limited auto-
proteolysis; m-calpain could be activated by μ-calpain 
[12]. Some genetic mutations of calpain-10 gene might 
be associated with an increased risk for NIDDM [7]. 
Altered expression of calpain 10 enzyme in pancreatic, 
muscle, and fat cells is related with abnormal glucose 
homeostasis through the modification of calpain 
10-dependent pathway [7]. Low levels of calpain-10 
mRNA in skeletal muscle were also associated with 
insulin resistance [13]. These findings suggested the 
related genetic and product expression of calpain-10 
might play a major role in determining the normal 
response of skeletal muscle to the effects of insulin.  
Several studies have confirmed the role of calpain 
10 as a diabetes susceptibility gene [7,18,19,27]. Hori-
kawa  et al. firstly demonstrated the association be-
tween calpain 10 and DM [7]. They also highlighted 
the novel  pathway of calpain system which contrib-
uted to the development of type 2 diabetes. The 
pharmacological inhibition of calpain might cause in-
sulin resistance of glucose transport in skeletal muscle 
[30]. The m-calpain can degrade glucose transporter 
turnover, which provide evidence for a physiological 
role of calpains in the adjustment of muscle glucose 
equilibrium and muscle mass [31]. The  cal-
cium-dependent protease µ-calpain is increased in the 
diabetic vasculature and that inhibition of calpain ac-
tivity attenuates the vascular dysfunction associated 
with chronic diabetes, which indicated a role of calpain 
in the pathophysiology of diabetic vascular  disease 
[32]. However, the mechanism regulating activity of 
the calpain system in-vivo is unknown.  
At the cell membrane, calpain is activated in the 
presence of calcium and phospholipids. Calpain exists 
in the cytosol as an inactive enzyme and translocates to 
membranes in response to increases in the cellular Ca2+ 
level [29]. Calpains usually exhibit in an inactive form 
and are activated by calcium and phospholipids 
[25,33]. Calpain activity might be regulated by binding 
of Ca2+ to specific sites on the calpain molecule, with 
binding to each site eliciting a response (proteolytic 
activity, calpastatin binding, etc.) specific for that site. 
Calpains might bind to specific proteins and not to Int. J. Biol. Sci. 2008, 4 
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phospholipids, and that binding to cell membranes 
does not affect the Ca2+ required for autolysis [32]. The 
binding of the calpains to phospholipid in a cell 
membrane might lower the Ca2+ concentration, which 
is required for the autolysis of calpains. Furthermore, 
the autolysis of calpains converts an inactive proen-
zyme into an active protease [14].   
Calcium-dependent protease calpain causes en-
dothelial dysfunction and vascular inflammation in 
the microcirculation of the ZDF (Zucker diabetic fatty) 
rat, a genetic rat model of type 2 diabetes [32]. The 
inhibition of calpain activity in skeletal muscle is re-
lated to equilibrium in muscle metabolism [31]. Some 
investigators observed the increased calpain activity 
and leukocyte trafficking in the microcirculation of 
ZDF rats [32]. They also noted that inhibition of cal-
pain activity significantly attenuated leuko-
cyte-endothelium interactions in the vasculature of 
ZDF rats. Expression of cell adhesion molecules in the 
vascular endothelium of ZDF rats was consistently 
increased. Furthermore, the calpain inhibition might 
suppress the adhesion molecules between leukocyte 
and endothelium [32]. Therefore, calpains might be-
come new molecular target for the prevention and 
treatment of diabetic vascular complications [32].  
Calpain-10 is a non-lysosomal cysteine protease 
expressed in many tissues, including skeletal muscle, 
liver, and pancreas [13]. Calpain-10 is the first diabetes 
gene to be identified through a genome scan [34]. 
However, the function of calpain-10 remains unclear 
[35]. Calpain-10 gene is associated with NIDDM sus-
ceptibility [10]. Some calpain-10 single nucleotide gene 
polymorphism (SNP) is associated with reduced mus-
cle mRNA levels and insulin resistance [13]. 
NIDDM-associated SNP-43*G-allele is associated with 
reduced calpain 10 mRNA levels, when compared to 
SNP-43*A-allele [36]. In contrast, some reports re-
vealed their non-associations. Insulin had no signifi-
cant effect upon calpain 10 mRNA levels [36]. In addi-
tion, age had no significant influence on calpain 10 
mRNA levels [36].  
In this survey, we observed the exercise de-
creased the expressions of both μ- and m-calpain 
mRNA, suggesting that the exercise might be related 
to the degradation of calpains in NIDDM rats. The 
calpain system changes after exercise might also in-
fluence and regulate the related pathways of glucose 
transport in skeletal muscle. Through the changes of 
body weight and the expressions of μ-calpain and 
m-calpain mRNA in skeletal muscle, exercises improve 
the physiopathology of diabetic individuals. We found 
the benefits of exercise upon these lean rats, which 
indicated the favor roles of exercise upon the lean in-
dividuals with diabetes. Our findings also highlighted 
the possibilities of the roles of these calpains as possi-
ble markers for prognoses diabetes.  
We also observed the lean Zucker rats with a 
Fa/Fa or Fa/fa genotype have decreased levels of 
calpain 10 mRNA. In contrast, there was no significant 
difference in calpain 10 expression between OE and OS 
groups. Furthermore, the calpain 10 expression of LS 
groups was lower than that pf LE groups. Our findings 
indicated that different biological mechanism and re-
lationship between the calpain system and lower body 
weight condition. It also suggested that calpain 10 
might not become useful marker for the diabetic 
screening.  
Xiang et al. [37] found that the OS rats had sig-
nificantly higher mean body weight, blood glucose, 
and insulin levels compared with the LS rats, whereas 
the OE had significantly lower blood glucose, and in-
sulin levels compared with the OS. These results sug-
gest that exercise training can improve body weight in 
the individuals with NIDDM [37]. Exercise training 
improves the insulin-stimulated glucose transport in 
muscle of the obese Zucker rats by increasing GLUT-4 
content and by altering the normal intracellular dis-
tribution of these transporters such that they are capa-
ble of migrating to the cell surface in response to the 
insulin stimulus [38].  
In this study, after 8 weeks exercise, we found the 
body weight difference between OS and OE rats was 
more significantly than that between LS and LE. These 
findings are in agreement with previous studies, 
which revealed that exercise training improves body 
weight controls of the obese rat. . The exercise training 
might be beneficial for lean rats too. We also observed 
the expressions of calpain 10, μ-calpain, and m-calpain 
in obese rats were higher than those in lean rats. These 
findings suggested that both exercise and low body 
weight play similar influences upon the decreasing 
calpains expressions or increasing the calpains degra-
dation, both were associated with glucose transport in 
the skeletal muscle of type 2 diabetes rats. The in-
creased body weight might up-regulate the calpain 
mRNA levels, whereas the exercise might 
down-regulated the related expression.  
In conclusion, exercise training decreases the 
body weight gaining in obese Zucker rats (type 2 dia-
betes). Exercise training appears to be an important 
determinant on the improvement of body weight con-
trol and expression of calpain-isoforms. The expres-
sions of calpain isoforms in skeletal muscle are regu-
lated by exercise training in both lean or obese Zucker 
rats, which suggest exercise can improve the glucose 
uptake into the contracting skeletal muscle in this 
model of NIDDM. The higher expressions of μ- or 
m-calpain mRNA might be risk factors for diabetic Int. J. Biol. Sci. 2008, 4 
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individuals. Both calpain-isoforms might become use-
ful markers to predict the progression or prognosis of 
NIDDM. In contrast, the calpain 10 might not become 
useful candidate marker for the NIDDM screening. 
Although the real roles of calpain-isoforms have not 
been clarified, it deserves more attentions in the study 
of related correlations and the molecular mechanisms. 
Lager cohort recruitment is request for its further 
clarification. After the resolutions of these issues, some 
calpain-isforms might become useful markers to pre-
dict the future monitoring or screening of diabetes as 
well as the elucidation of related underlying pathways. 
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